Correlation Between Varicella Zoster Virus (VZV)–Specific Cell-Mediated and Humoral Immunity After Zoster Vaccine (ZV) Administration, Using Pooled Analysis
Variable . | First-Time ZV Recipients Aged ≥50 Years Old (Groups 2–4) . | Booster ZV Recipients Aged ≥70 Years Old (Group 1) . | ||||
---|---|---|---|---|---|---|
Participants, No. . | Coefficient of Correlation . | P Value . | Participants, No. . | Coefficient of Correlation . | P Value . | |
Baseline gpELISA findings | ||||||
Total effector | 393 | 0.091 | .072 | 195 | 0.104 | .147 |
Effector memory | 390 | 0.137 | .007 | 194 | 0.102 | .157 |
Total memory | 393 | 0.075 | .138 | 196 | 0.074 | .304 |
Central memory | 379 | 0.055 | .283 | 194 | 0.0414 | .566 |
Differentiated effector | 344 | 0.057 | .293 | 161 | 0.0904 | .256 |
Week 6 gpELISA and week 1 ELISPOT findings | ||||||
Total effector | 386 | 0.218 | <.0001 | 198 | 0.222 | .002 |
Effector memory | 385 | 0.295 | <.0001 | 196 | 0.168 | .019 |
Total memory | 386 | 0.2165 | <.0001 | 194 | 0.224 | .002 |
Central memory | 378 | 0.148 | .004 | 192 | 0.284 | <.0001 |
Differentiated effector | 375 | 0.20321 | <.0001 | 195 | 0.229 | .001 |
Week 6 gpELISA and week 6 ELISPOT findings | ||||||
Total effector | 387 | 0.233 | <.0001 | 198 | 0.166 | .020 |
Effector memory | 385 | 0.255 | <.0001 | 197 | 0.174 | .015 |
Total memory | 390 | 0.182 | .001 | 194 | 0.137 | .056 |
Central memory | 382 | 0.061 | .2316 | 192 | 0.082 | .260 |
Differentiated effector | 354 | 0.152 | .004 | 180 | 0.226 | .002 |
Week 6 gpELISA and week 52 ELISPOT findings | ||||||
Total effector | 342 | 0.167 | .002 | 182 | 0.183 | .013 |
Effector memory | 340 | 0.12587 | .020 | 181 | 0.179 | .016 |
Total memory | 344 | 0.107 | .048 | 180 | 0.107 | .152 |
Central memory | 335 | 0.061 | .263 | 176 | 0.144 | .056 |
Differentiated effector | 308 | 0.157 | .006 | 165 | 0.094 | .232 |
Week 6/baseline gpELISA and week 1 ELISPOT findings | ||||||
Total effector | 386 | 0.140 | .006 | 198 | 0.084 | .239 |
Effector memory | 385 | 0.144 | .005 | 196 | 0.091 | .205 |
Total memory | 386 | 0.131 | .010 | 194 | 0.124 | .085 |
Central memory | 378 | 0.093 | .070 | 192 | 0.127 | .079 |
Differentiated effector | 375 | 0.113 | .029 | 195 | 0.034 | .635 |
Week 6 gpELISA/baseline and week 6 ELISPOT findings | ||||||
Total effector | 387 | 0.139 | .006 | 198 | 0.025 | .726 |
Effector memory | 385 | 0.130 | .010 | 197 | 0.050 | .484 |
Total memory | 390 | 0.106 | .036 | 194 | 0.061 | .402 |
Central memory | 382 | 0.068 | .188 | 192 | 0.038 | .598 |
Differentiated effector | 354 | 0.106 | .046 | 180 | 0.011 | .885 |
Week 6/baseline gpELISA and week 52 ELISPOT findings | ||||||
Total effector | 342 | 0.198 | <.001 | 182 | −0.007 | .922 |
Effector memory | 340 | 0.210 | .0001 | 181 | 0.021 | .776 |
Total memory | 344 | 0.176 | .001 | 180 | 0.016 | .830 |
Central memory | 335 | 0.094 | .084 | 176 | 0.031 | .679 |
Differentiated effector | 308 | 0.122 | .033 | 165 | −0.070 | .370 |
Variable . | First-Time ZV Recipients Aged ≥50 Years Old (Groups 2–4) . | Booster ZV Recipients Aged ≥70 Years Old (Group 1) . | ||||
---|---|---|---|---|---|---|
Participants, No. . | Coefficient of Correlation . | P Value . | Participants, No. . | Coefficient of Correlation . | P Value . | |
Baseline gpELISA findings | ||||||
Total effector | 393 | 0.091 | .072 | 195 | 0.104 | .147 |
Effector memory | 390 | 0.137 | .007 | 194 | 0.102 | .157 |
Total memory | 393 | 0.075 | .138 | 196 | 0.074 | .304 |
Central memory | 379 | 0.055 | .283 | 194 | 0.0414 | .566 |
Differentiated effector | 344 | 0.057 | .293 | 161 | 0.0904 | .256 |
Week 6 gpELISA and week 1 ELISPOT findings | ||||||
Total effector | 386 | 0.218 | <.0001 | 198 | 0.222 | .002 |
Effector memory | 385 | 0.295 | <.0001 | 196 | 0.168 | .019 |
Total memory | 386 | 0.2165 | <.0001 | 194 | 0.224 | .002 |
Central memory | 378 | 0.148 | .004 | 192 | 0.284 | <.0001 |
Differentiated effector | 375 | 0.20321 | <.0001 | 195 | 0.229 | .001 |
Week 6 gpELISA and week 6 ELISPOT findings | ||||||
Total effector | 387 | 0.233 | <.0001 | 198 | 0.166 | .020 |
Effector memory | 385 | 0.255 | <.0001 | 197 | 0.174 | .015 |
Total memory | 390 | 0.182 | .001 | 194 | 0.137 | .056 |
Central memory | 382 | 0.061 | .2316 | 192 | 0.082 | .260 |
Differentiated effector | 354 | 0.152 | .004 | 180 | 0.226 | .002 |
Week 6 gpELISA and week 52 ELISPOT findings | ||||||
Total effector | 342 | 0.167 | .002 | 182 | 0.183 | .013 |
Effector memory | 340 | 0.12587 | .020 | 181 | 0.179 | .016 |
Total memory | 344 | 0.107 | .048 | 180 | 0.107 | .152 |
Central memory | 335 | 0.061 | .263 | 176 | 0.144 | .056 |
Differentiated effector | 308 | 0.157 | .006 | 165 | 0.094 | .232 |
Week 6/baseline gpELISA and week 1 ELISPOT findings | ||||||
Total effector | 386 | 0.140 | .006 | 198 | 0.084 | .239 |
Effector memory | 385 | 0.144 | .005 | 196 | 0.091 | .205 |
Total memory | 386 | 0.131 | .010 | 194 | 0.124 | .085 |
Central memory | 378 | 0.093 | .070 | 192 | 0.127 | .079 |
Differentiated effector | 375 | 0.113 | .029 | 195 | 0.034 | .635 |
Week 6 gpELISA/baseline and week 6 ELISPOT findings | ||||||
Total effector | 387 | 0.139 | .006 | 198 | 0.025 | .726 |
Effector memory | 385 | 0.130 | .010 | 197 | 0.050 | .484 |
Total memory | 390 | 0.106 | .036 | 194 | 0.061 | .402 |
Central memory | 382 | 0.068 | .188 | 192 | 0.038 | .598 |
Differentiated effector | 354 | 0.106 | .046 | 180 | 0.011 | .885 |
Week 6/baseline gpELISA and week 52 ELISPOT findings | ||||||
Total effector | 342 | 0.198 | <.001 | 182 | −0.007 | .922 |
Effector memory | 340 | 0.210 | .0001 | 181 | 0.021 | .776 |
Total memory | 344 | 0.176 | .001 | 180 | 0.016 | .830 |
Central memory | 335 | 0.094 | .084 | 176 | 0.031 | .679 |
Differentiated effector | 308 | 0.122 | .033 | 165 | −0.070 | .370 |
Total effector cells were measured on the basis of spot-forming cells (SFCs) secreting interferon γ (IFN-γ), with or without secretion of interleukin 2 (IL-2); effector memory cells were measured on the basis of SFCs secreting IFN-γ and IL-2; total memory cells were measured on the basis of SFCs secreting IL-2, with or without secretion of IFN-γ; central memory cells were measured on the basis of SFCs secreting IL-2 but not IFN-γ; and differentiated effector cells were measured on the basis of SFCs secreting IFN-γ but not IL-2.
Abbreviations: ELISPOT, enzyme-linked immunosorbent spot; gpELISA, VZV glycoprotein–based enzyme-linked immunosorbent assay.
Correlation Between Varicella Zoster Virus (VZV)–Specific Cell-Mediated and Humoral Immunity After Zoster Vaccine (ZV) Administration, Using Pooled Analysis
Variable . | First-Time ZV Recipients Aged ≥50 Years Old (Groups 2–4) . | Booster ZV Recipients Aged ≥70 Years Old (Group 1) . | ||||
---|---|---|---|---|---|---|
Participants, No. . | Coefficient of Correlation . | P Value . | Participants, No. . | Coefficient of Correlation . | P Value . | |
Baseline gpELISA findings | ||||||
Total effector | 393 | 0.091 | .072 | 195 | 0.104 | .147 |
Effector memory | 390 | 0.137 | .007 | 194 | 0.102 | .157 |
Total memory | 393 | 0.075 | .138 | 196 | 0.074 | .304 |
Central memory | 379 | 0.055 | .283 | 194 | 0.0414 | .566 |
Differentiated effector | 344 | 0.057 | .293 | 161 | 0.0904 | .256 |
Week 6 gpELISA and week 1 ELISPOT findings | ||||||
Total effector | 386 | 0.218 | <.0001 | 198 | 0.222 | .002 |
Effector memory | 385 | 0.295 | <.0001 | 196 | 0.168 | .019 |
Total memory | 386 | 0.2165 | <.0001 | 194 | 0.224 | .002 |
Central memory | 378 | 0.148 | .004 | 192 | 0.284 | <.0001 |
Differentiated effector | 375 | 0.20321 | <.0001 | 195 | 0.229 | .001 |
Week 6 gpELISA and week 6 ELISPOT findings | ||||||
Total effector | 387 | 0.233 | <.0001 | 198 | 0.166 | .020 |
Effector memory | 385 | 0.255 | <.0001 | 197 | 0.174 | .015 |
Total memory | 390 | 0.182 | .001 | 194 | 0.137 | .056 |
Central memory | 382 | 0.061 | .2316 | 192 | 0.082 | .260 |
Differentiated effector | 354 | 0.152 | .004 | 180 | 0.226 | .002 |
Week 6 gpELISA and week 52 ELISPOT findings | ||||||
Total effector | 342 | 0.167 | .002 | 182 | 0.183 | .013 |
Effector memory | 340 | 0.12587 | .020 | 181 | 0.179 | .016 |
Total memory | 344 | 0.107 | .048 | 180 | 0.107 | .152 |
Central memory | 335 | 0.061 | .263 | 176 | 0.144 | .056 |
Differentiated effector | 308 | 0.157 | .006 | 165 | 0.094 | .232 |
Week 6/baseline gpELISA and week 1 ELISPOT findings | ||||||
Total effector | 386 | 0.140 | .006 | 198 | 0.084 | .239 |
Effector memory | 385 | 0.144 | .005 | 196 | 0.091 | .205 |
Total memory | 386 | 0.131 | .010 | 194 | 0.124 | .085 |
Central memory | 378 | 0.093 | .070 | 192 | 0.127 | .079 |
Differentiated effector | 375 | 0.113 | .029 | 195 | 0.034 | .635 |
Week 6 gpELISA/baseline and week 6 ELISPOT findings | ||||||
Total effector | 387 | 0.139 | .006 | 198 | 0.025 | .726 |
Effector memory | 385 | 0.130 | .010 | 197 | 0.050 | .484 |
Total memory | 390 | 0.106 | .036 | 194 | 0.061 | .402 |
Central memory | 382 | 0.068 | .188 | 192 | 0.038 | .598 |
Differentiated effector | 354 | 0.106 | .046 | 180 | 0.011 | .885 |
Week 6/baseline gpELISA and week 52 ELISPOT findings | ||||||
Total effector | 342 | 0.198 | <.001 | 182 | −0.007 | .922 |
Effector memory | 340 | 0.210 | .0001 | 181 | 0.021 | .776 |
Total memory | 344 | 0.176 | .001 | 180 | 0.016 | .830 |
Central memory | 335 | 0.094 | .084 | 176 | 0.031 | .679 |
Differentiated effector | 308 | 0.122 | .033 | 165 | −0.070 | .370 |
Variable . | First-Time ZV Recipients Aged ≥50 Years Old (Groups 2–4) . | Booster ZV Recipients Aged ≥70 Years Old (Group 1) . | ||||
---|---|---|---|---|---|---|
Participants, No. . | Coefficient of Correlation . | P Value . | Participants, No. . | Coefficient of Correlation . | P Value . | |
Baseline gpELISA findings | ||||||
Total effector | 393 | 0.091 | .072 | 195 | 0.104 | .147 |
Effector memory | 390 | 0.137 | .007 | 194 | 0.102 | .157 |
Total memory | 393 | 0.075 | .138 | 196 | 0.074 | .304 |
Central memory | 379 | 0.055 | .283 | 194 | 0.0414 | .566 |
Differentiated effector | 344 | 0.057 | .293 | 161 | 0.0904 | .256 |
Week 6 gpELISA and week 1 ELISPOT findings | ||||||
Total effector | 386 | 0.218 | <.0001 | 198 | 0.222 | .002 |
Effector memory | 385 | 0.295 | <.0001 | 196 | 0.168 | .019 |
Total memory | 386 | 0.2165 | <.0001 | 194 | 0.224 | .002 |
Central memory | 378 | 0.148 | .004 | 192 | 0.284 | <.0001 |
Differentiated effector | 375 | 0.20321 | <.0001 | 195 | 0.229 | .001 |
Week 6 gpELISA and week 6 ELISPOT findings | ||||||
Total effector | 387 | 0.233 | <.0001 | 198 | 0.166 | .020 |
Effector memory | 385 | 0.255 | <.0001 | 197 | 0.174 | .015 |
Total memory | 390 | 0.182 | .001 | 194 | 0.137 | .056 |
Central memory | 382 | 0.061 | .2316 | 192 | 0.082 | .260 |
Differentiated effector | 354 | 0.152 | .004 | 180 | 0.226 | .002 |
Week 6 gpELISA and week 52 ELISPOT findings | ||||||
Total effector | 342 | 0.167 | .002 | 182 | 0.183 | .013 |
Effector memory | 340 | 0.12587 | .020 | 181 | 0.179 | .016 |
Total memory | 344 | 0.107 | .048 | 180 | 0.107 | .152 |
Central memory | 335 | 0.061 | .263 | 176 | 0.144 | .056 |
Differentiated effector | 308 | 0.157 | .006 | 165 | 0.094 | .232 |
Week 6/baseline gpELISA and week 1 ELISPOT findings | ||||||
Total effector | 386 | 0.140 | .006 | 198 | 0.084 | .239 |
Effector memory | 385 | 0.144 | .005 | 196 | 0.091 | .205 |
Total memory | 386 | 0.131 | .010 | 194 | 0.124 | .085 |
Central memory | 378 | 0.093 | .070 | 192 | 0.127 | .079 |
Differentiated effector | 375 | 0.113 | .029 | 195 | 0.034 | .635 |
Week 6 gpELISA/baseline and week 6 ELISPOT findings | ||||||
Total effector | 387 | 0.139 | .006 | 198 | 0.025 | .726 |
Effector memory | 385 | 0.130 | .010 | 197 | 0.050 | .484 |
Total memory | 390 | 0.106 | .036 | 194 | 0.061 | .402 |
Central memory | 382 | 0.068 | .188 | 192 | 0.038 | .598 |
Differentiated effector | 354 | 0.106 | .046 | 180 | 0.011 | .885 |
Week 6/baseline gpELISA and week 52 ELISPOT findings | ||||||
Total effector | 342 | 0.198 | <.001 | 182 | −0.007 | .922 |
Effector memory | 340 | 0.210 | .0001 | 181 | 0.021 | .776 |
Total memory | 344 | 0.176 | .001 | 180 | 0.016 | .830 |
Central memory | 335 | 0.094 | .084 | 176 | 0.031 | .679 |
Differentiated effector | 308 | 0.122 | .033 | 165 | −0.070 | .370 |
Total effector cells were measured on the basis of spot-forming cells (SFCs) secreting interferon γ (IFN-γ), with or without secretion of interleukin 2 (IL-2); effector memory cells were measured on the basis of SFCs secreting IFN-γ and IL-2; total memory cells were measured on the basis of SFCs secreting IL-2, with or without secretion of IFN-γ; central memory cells were measured on the basis of SFCs secreting IL-2 but not IFN-γ; and differentiated effector cells were measured on the basis of SFCs secreting IFN-γ but not IL-2.
Abbreviations: ELISPOT, enzyme-linked immunosorbent spot; gpELISA, VZV glycoprotein–based enzyme-linked immunosorbent assay.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.